Comparing the effects of subchronic phencyclidine and medial prefrontal cortex dysfunction on cognitive tests relevant to schizophrenia.
K A L McAllister, A C Mar, D E Theobald, L M Saksida, T J Bussey
Psychopharmacology November 1, 2015 DOI: 10.1007/s00213-015-4018-7 via PubMed
Summary
AI-generated from the abstractA double-dissociation was found between two cognitive tasks in rats: dysfunction of the medial prefrontal cortex impaired learning of object-location associations but not spontaneous novel object recognition, while subchronic phencyclidine (scPCP) impaired novel object recognition but not object-location associative learning. Both scPCP and mPFC dysfunction similarly facilitated reversal learning. The pattern of impairment after scPCP raises questions about its validity as a model of cognitive impairment in schizophrenia, especially if faithfully replicating the effects of mPFC dysfunction is important.
Study at a glance
| Characteristics | Animal model comparison study Peer reviewed |
|---|---|
| Population | Rats |
| Intervention | Phencyclidine |
| Dose | 5 mg/kg PCP twice daily for 1 week |
| Duration | 1-week dosing, 1-week washout, then behavioral testing |
| Keywords | Animal model Associative learning Discrimination Glutamate Learning and memory |
| Key finding | Subchronic phencyclidine and medial prefrontal cortex dysfunction produce a double-dissociation in cognitive tasks, with scPCP impairing object recognition but not object-location learning, while mPFC dysfunction impairs object-location learning but not object recognition. |
Abstract
It is becoming increasingly clear that the development of treatments for cognitive symptoms of schizophrenia requires urgent attention, and that valid animal models of relevant impairments are required. With subchronic psychotomimetic agent phencyclidine (scPCP), a putative model of such impairment, the extent to which changes following scPCP do or do not resemble those following dysfunction of the prefrontal cortex is of importance. The present study carried out a comparison of the most common scPCP dosing regimen with excitotoxin-induced medial prefrontal cortex (mPFC) dysfunction in rats, across several cognitive tests relevant to schizophrenia. ScPCP subjects were dosed intraperitoneal with 5 mg/kg PCP or vehicle twice daily for 1 week followed by 1 week washout prior to behavioural testing. mPFC dysfunction was induced via fibre-sparing excitotoxin infused into the pre-limbic and infralimbic cortex. Subjects were tested on spontaneous novel object recognition, touchscreen object-location paired-associates learning and touchscreen reversal learning. A double-dissociation was observed between object-location paired-associates learning and object recognition: mPFC dysfunction impaired acquisition of the object-location task but not spontaneous novel object recognition, while scPCP impaired spontaneous novel object recognition but not object-location associative learning. Both scPCP and mPFC dysfunction resulted in a similar facilitation of reversal learning. The pattern of impairment following scPCP raises questions around its efficacy as a model of cognitive impairment in schizophrenia, particularly if importance is placed on faithfully replicating the effects of mPFC dysfunction.